Table 2.

Chikungunya vaccines in clinical trials65, 66, 67, 68, 69, 70, 71

Platform	Vaccine	Vaccine Type	Clinical Trial Phase
Live, attenuated	VLA1553	CHIKV with nsP3 deletion	3
	MV-CHIK	Recombinant live, attenuated measles vaccine expressing CHIKV VLP structural proteins	2
VLP	VRC-CHKVLP059-00-VP (PXVX0317 CHIKV-VLP)	VLP with plasmid expressing CHIKV structural proteins (West African strain 37997)	2
Whole-virus inactivated vaccine	BBV87	Inactivated whole-virion vaccine based on East, Central, South, African genotypea	1
Viral vector	ChAdOx1 Chik	Replication-deficient simian adenoviral vector expressing CHIKV antigens	1